Final evaluation of HCV patients treated with 12 week regimens containing sofosbuvir +/- simeprevir in the TRIO network: academic and community treatment of a real-world, heterogeneous population

Press/Media: Press / Media

PeriodMay 1 2015

Media coverage

1

Media coverage

  • TitleFinal evaluation of HCV patients treated with 12 week regimens containing sofosbuvir +/- simeprevir in the TRIO network: academic and community treatment of a real-world, heterogeneous population
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date5/1/15
    PersonsEric J Lawitz